Mesa Laboratories, Inc. (MLAB)
| Market Cap | 1.06B |
| Revenue (ttm) | 199.87M |
| Net Income (ttm) | -1.56M |
| Shares Out | 5.32M |
| EPS (ttm) | 0.34 |
| PE Ratio | 587.91 |
| Forward PE | 35.21 |
| Dividend | $0.64 (0.32%) |
| Ex-Dividend Date | Aug 30, 2022 |
| Volume | 15,090 |
| Open | 198.72 |
| Previous Close | 199.66 |
| Day's Range | 195.48 - 201.81 |
| 52-Week Range | 178.32 - 333.42 |
| Beta | 0.52 |
| Analysts | Buy |
| Price Target | 237.15 (+18.6%) |
| Earnings Date | Aug 3, 2022 |
About MLAB
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to t... [Read more...]
Financial Performance
In 2021, MLAB's revenue was $184.34 million, an increase of 37.63% compared to the previous year's $133.94 million. Earnings were $1.87 million, a decrease of -42.85%.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for MLAB stock is "Buy." The 12-month stock price forecast is 237.15, which is an increase of 18.64% from the latest price.
News
Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -40% and 4.14%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Announces First Quarter Results
LAKEWOOD, Colo., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its first fiscal quarter (“1Q23”).
Mesa Labs (MLAB) to Report Q1 Results: Wall Street Expects Earnings Growth
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MESA LABS DECLARES QUARTERLY DIVIDEND
Lakewood, CO, July 06, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly...
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the “Board”), effective June 23, 2022. Tony ...
Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of 18.09% and 6.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”) and full year ended March 31, 2022 (“FY22”).
Mesa Labs Declares Quarterly Dividend
LAKEWOOD, Colo., April 06, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarte...
Mesa Labs (MLAB) Q3 Earnings Miss Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -19.05% and 13.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Announces Third Quarter Results
LAKEWOOD, Colo., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for its third fiscal quarter (“3Q22”) and nine months ended December 31, 2021.
Mesa Labs (MLAB) Earnings Expected to Grow: Should You Buy?
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
These smaller healthcare companies all have 10x potential for investors.
What History Shows Us About 2022 Market Returns
What to Expect From the Markets In 2022
Bull of the Day: Mesa Laboratories (MLAB)
Another solid quarter and growth ahead in genetic diagnostic services makes this small cap a buy
Mesa Labs (MLAB) Q2 Earnings and Revenues Surpass Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of 44.96% and 2.55%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Announces Second Quarter Results
LAKEWOOD, Colo., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its second fiscal quarter (“2Q22”) and six months ended September 30, 2021.
Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs Closes Acquisition of Agena Bioscience
LAKEWOOD, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc. With this h...
Mesa Labs (MLAB) Moves 4.5% Higher: Will This Strength Last?
Mesa Labs (MLAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical qualit...
Mesa Labs (MLAB) Lags Q1 Earnings Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -5.88% and 2.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Mesa Laboratories: Q4 Earnings Insights
Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98, which beat the estimate of ...
Mesa Labs (MLAB) to Report Q4 Results: Wall Street Expects Earnings Growth
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs (MLAB) Lags Q3 Earnings Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -0.68% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?